Alliance Trust Savings appoints ex-Friends Life finance boss as chairman

Tim Tookey joins board

Anna Fedorova
clock • 1 min read

Alliance Trust Savings has appointed Tim Tookey as chairman of its board, after becoming an independent standalone business, with its own management and board.

Tookey (pictured) is currently also non-executive director of Nationwide Building Society, having joined its board in June 2015. Prior to that, he spent three years as chief financial officer at Friends Life Group and six years with Lloyds Banking Group, rising to group finance director. He has also held senior finance roles within Prudential and Heath Lambert Group, and spent ten years at KPMG where he qualified as a chartered accountant in 1988. In his new role as chairman, Tookey will work with existing non-executive directors, Jonathan Anderson and Gregor Stewart, who joined th...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Companies

PFS' Carla Brown: 'We've built a stronger, more constructive relationship with the CII'

PFS' Carla Brown: 'We've built a stronger, more constructive relationship with the CII'

Professional body has ‘come through some challenging years’

Isabel Baxter
clock 13 November 2025 • 2 min read
WH Ireland confirms takeover approach from Team

WH Ireland confirms takeover approach from Team

10 December deadline

Sahar Nazir
clock 13 November 2025 • 1 min read
FNZ raises $650m in funding from institutional shareholders

FNZ raises $650m in funding from institutional shareholders

Aviva, Aberdeen, and Nucleus part of backing

Isabel Baxter
clock 12 November 2025 • 1 min read